Tyra Biosciences Inc (TYRA)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $1.38B
Last updated: Nov 17, 2026 at 11:06 AM ET
Tyra Biosciences Inc (TYRA) Competitors
The companies most similar to Tyra Biosciences are Structure Therapeutics Inc. American Depositary Shares (GPCR), Beam Therapeutics (BEAM) and Forte Biosciences (FBRX). By market cap, Tyra Biosciences ranks 9th of the 13 companies on this page; Arcus Biosciences (RCUS) is the largest at $2.51B.
Peer Comparison
TYRA's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Tyra Biosciences (TYRA) | $1.38B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Structure Therapeutics Inc. American Depositary Shares (GPCR) | $1.43B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| Forte Biosciences Inc (FBRX) | $1.63B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vir Biotechnology Inc (VIR) | $1.71B | N/A | 5.4x | -61.0% | N/A | 19582.0% | 0.00% |
| Tourmaline Bio Inc. (TRML) | $1.23B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Theravance Biopharma Inc (TBPH) | $884.18M | 95.1x | 8.4x | 51.6% | N/A | -20.9% | 0.00% |
| Taysha Gene Therapies Inc (TSHA) | $1.34B | N/A | 300.6x | 0.0% | -32.8% | 171.3% | 0.00% |
| Arcus Biosciences Inc (RCUS) | $2.51B | N/A | 21.5x | 0.0% | -75.9% | -65.4% | 0.00% |
| Fortrea Holdings Inc. (FTRE) | $1.95B | 26.0x | 0.7x | -2.6% | 1.8% | -1.4% | 0.00% |
| Nuvation Bio Inc (NUVB) | $1.41B | N/A | 6.7x | -67.4% | -18.7% | 242.6% | 0.00% |
| Vor Biopharma Inc (VOR) | $1.19B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Vera Therapeutics Inc (VERA) | $2.03B | N/A | 189.3x | 0.0% | -83.0% | 0.0% | 0.00% |
| Peer median | $1.53B | 60.6x | 11.7x | 0.0% | -31.2% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Tyra Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Structure Therapeutics Inc. American Depositary Shares (GPCR) | Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral therapeutics to treat a range of chronic... | GPCR competitors |
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| Forte Biosciences Inc (FBRX) | Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company is headquartered in Torrance, California. | |
| Vir Biotechnology Inc (VIR) | Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. | VIR competitors |
| Tourmaline Bio Inc. (TRML) | Tourmaline Bio Inc. is a pioneering biotechnology firm dedicated to developing cutting-edge cell therapies targeting severe and life-threatening conditions... | |
| Theravance Biopharma Inc (TBPH) | Theravance Biopharma, Inc., a diversified biopharmaceutical company, discovers, develops, and markets organ-selective drugs in the United States, Europe... | |
| Taysha Gene Therapies Inc (TSHA) | Taysha Gene Therapies, Inc., a gene therapy company, focuses on the development and commercialization of adeno-associated virus-based gene therapies... | TSHA competitors |
| Arcus Biosciences Inc (RCUS) | Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and markets cancer therapies in the United States. | RCUS competitors |
| Fortrea Holdings Inc. (FTRE) | Fortrea Holdings Inc. provides clinical development and patient access solutions to the life sciences industry. | FTRE competitors |
| Nuvation Bio Inc (NUVB) | Nuvation Bio Inc., a clinical-stage biopharmaceutical company, is focused on developing therapeutic candidates for oncology. | NUVB competitors |
| Vor Biopharma Inc (VOR) | Vor Biopharma, Inc., an early stage cell therapy company, develops hematopoietic stem cell (eHSC) therapies designed for cancer patients. | VOR competitors |
| Vera Therapeutics Inc (VERA) | Vera Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immune diseases... | VERA competitors |
Frequently Asked Questions About TYRA
Who are Tyra Biosciences' main competitors?
The companies most similar to Tyra Biosciences include Structure Therapeutics Inc. American Depositary Shares (GPCR), Beam Therapeutics (BEAM), Forte Biosciences (FBRX), Vir Biotechnology (VIR) and Tourmaline Bio (TRML), listed from the closest match.
Who is Tyra Biosciences' biggest competitor?
Arcus Biosciences (RCUS) is the largest of the similar companies at $2.51B; Structure Therapeutics Inc. American Depositary Shares (GPCR) is the closest match by business profile, size, sector and industry.
How does TYRA stock compare with its competitors?
TYRA's net margin is 0.0% against a peer median of 0.0%.
Which of Tyra Biosciences' competitors pays a higher dividend?
Tyra Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Tyra Biosciences bigger than its competitors?
No. Tyra Biosciences is 9th by market cap among the 13 companies on this page; the largest is Arcus Biosciences (RCUS) at $2.51B.
TYRA pages: Overview, Earnings, Forecast, Financials, Competitors